Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

BACKGROUND: Early-stage breast cancer patients treated with chemotherapy risk the development of metabolic disease and weight gain, which can result in increased morbidity and reduced quality of life in survivorship. We aimed to analyze changes within the gastrointestinal microbiome of early-stage b...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, John, Joy, Anil Abraham, Vos, Larissa J., Stenson, Trevor H., Mackey, John R., Jovel, Juan, Kao, Dina, Madsen, Karen L., Wong, Gane Ka-Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173591/
https://www.ncbi.nlm.nih.gov/pubmed/37170273
http://dx.doi.org/10.1186/s12916-023-02751-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173591/
https://www.ncbi.nlm.nih.gov/pubmed/37170273
http://dx.doi.org/10.1186/s12916-023-02751-8

Ejemplares similares